Previous 10 | Next 10 |
Shares of Cassava Sciences (NASDAQ: SAVA) , a clinical-stage biopharmaceutical company , plunged Wednesday after The Wall Street Journal published an article reporting that the Securities and Exchange Commission is investigating allegations about the company that surface...
Gainers: InMed Pharmaceuticals INM +40%. EyePoint Pharmaceuticals EYPT +27%. Where Food Comes From (NASDAQ:WFCF) +20%. Camber Energy (NYSE:CEI) +19%. Zhangmen Education (NYSE:ZME) +16%. Dogness (NASDAQ:DOGZ) +16%. Tattooed Chef TTCF +13%. On Holding ONON +13%. Jowell Globa...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Roku (NASDAQ: ROKU ) stock price predictions aren’t doing the shares any favors on Wednesday after one analyst put out a bearish take. Source: JHVEPhoto/Shutterstock.com The news hitting ROKU stock toda...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cassava Sciences (NASDAQ: SAVA ) stock is on the move Wednesday as investors react to reports of a U.S. Securities and Exchange Commission (SEC) investigation. Source: Pavel Kapysh / Shutterstock.com According...
Gainers: InMed Pharmaceuticals (NASDAQ:INM) +47%, EyePoint Pharmaceuticals (NASDAQ:EYPT) +24%, Varex Imaging (NASDAQ:VREX) +12%, OptiNose (NASDAQ:OPTN) +10%, Talkspace (NASDAQ:TALK) +7%. Losers: Cassava Sciences (NASDAQ:SAVA) -26%, Eloxx Pharm...
The U.S. Securities & Exchange Commission (SEC) has begun an investigation into Cassava Sciences (NASDAQ:SAVA) whether the company has manipulated study results for its investigational Alzheimer’s drug, The Wall Street Journal reported citing people familiar with the matter. Cassav...
Cassava Sciences is a clinical-stage Alzheimer's Disease (AD) drug developer that has become a battleground stock of sort. Many statements, both positive and negative, have been made regarding the data generated in their AD program. I consider some of these statements and share my...
Palm Beach, FL –November 16, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has affected the healthcare systems globally and also has a significant impact on the cancer therapy market. As per the article published in Cancer Connect 202...
Cassava Sciences (NASDAQ:SAVA) has lost ~5.0% in the pre-market after disclosing in its latest 10-Q filing that certain government agencies have asked the company to provide them with corporate information and documents. The company shares sank in August amid reports of a Citiz...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
News, Short Squeeze, Breakout and More Instantly...
Cassava Sciences, Inc. (NASDAQ: SAVA) is one of today's top gainers. The company's shares have moved 24.9% on the day to $12.59. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...